A common blood test for ovarian cancer is more likely to fall short for Black and Native American women, according to a new ...

Researcher suggests compounds secreted by high-risk MSCs that are detectable in the bloodstream could act as biomarkers for ...

In other words, their healthspan falls far short of their lifespan. And a lot of that comes down to their ovaries. Ovaries, the female gonads, play a pivotal role not only in reproduction but also ...

A TROP2-directed antibody-drug conjugate, DB-1305/BNT325, demonstrated durable activity in patients with previously treated ovarian cancer in a first-in-human trial. These results were presented at ...

A common blood test may miss ovarian cancer in some Black and Native American patients, delaying their treatment, a new study finds. It’s the latest example of medical tests that contribute to ...

Tumours, such as some breast and ovarian cancers, can express the marker HER2. HER2 is responsible for cancer growth and is the target of existing therapies, such as the most commonly used type of ...

Luveltamab tazevibulin demonstrated activity in an ongoing phase 2/3 trial of patients with FRα-positive, platinum-resistant ovarian cancer.

When ovarian cancer moves beyond your ovaries or fallopian tubes, cancer cells may reach your liver, lungs, or other places in your body. The stage your doctor assigns to your ovarian cancer can ...

Ovarian cancer can affect anyone born with female reproductive organs including the ovaries and fallopian tubes. This includes women, transgender men and non-binary people. We don’t know what causes ...